News
CL's strategic pricing, margin gains and productivity moves support steady EPS growth into 2025 despite cost pressures.
Colgate-Palmolive Company (NYSE:CL) is one of the Best Stagflation Stocks to Buy Now. On May 28, Piper Sandler reiterated its ...
Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation ...
StockStory.org on MSN6d
Colgate-Palmolive (CL): Buy, Sell, or Hold Post Q1 Earnings?Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last ...
Colgate-Palmolive Webcasts Fireside Chat at the Goldman Sachs Global Staples Forum Business Wire Apr 29, 2025, 2:15:00 PM Colgate-Palmolive Webcasts 2025 Annual Meeting of Stockholders May 9, 2025 ...
StockStory.org on MSN17d
5 Must-Read Analyst Questions From Colgate-Palmolive’s Q1 Earnings CallColgate-Palmolive's first quarter results were shaped by weaker consumer demand and category softness across key markets, with management attributing volume stagnation to both macroeconomic ...
Colgate-Palmolive has launched the Oral Health Movement aiming to improve India's oral care by utilizing technology and partnerships. With 4.5 million screenings conducted and vital insights gathered, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results